These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A developing country perspective on vaccine-associated paralytic poliomyelitis. John TJ Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301 [TBL] [Abstract][Full Text] [Related]
7. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary. Estívariz CF; Molnár Z; Venczel L; Kapusinszky B; Zingeser JA; Lipskaya GY; Kew OM; Berencsi G; Csohán A Am J Epidemiol; 2011 Aug; 174(3):316-25. PubMed ID: 21685412 [TBL] [Abstract][Full Text] [Related]
9. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Kohler KA; Banerjee K; Gary Hlady W; Andrus JK; Sutter RW Bull World Health Organ; 2002; 80(3):210-6. PubMed ID: 11984607 [TBL] [Abstract][Full Text] [Related]
10. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)]. Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594 [TBL] [Abstract][Full Text] [Related]
11. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran. Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391 [TBL] [Abstract][Full Text] [Related]
12. Vaccine-associated paralytic poliomyelitis: a case report of flaccid monoparesis after oral polio vaccine. Kim SJ; Kim SH; Jee YM; Kim JS J Korean Med Sci; 2007 Apr; 22(2):362-4. PubMed ID: 17449951 [TBL] [Abstract][Full Text] [Related]
13. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model. Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246 [TBL] [Abstract][Full Text] [Related]